Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,625 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multicenter phase I/II study of chemoradiotherapy with high-dose CDDP for head and neck squamous cell carcinoma in Japan.
Matsuyama H, Yamazaki K, Okabe R, Ueki Y, Shodo R, Omata J, Sato Y, Ota H, Takahashi T, Tomita M, Yokoyama Y, Togashi T, Aoyama H, Abe E, Saijo Y, Katsura K, Soga M, Sugita T, Matsumoto Y, Tsuchida E, Horii A. Matsuyama H, et al. Among authors: yokoyama y. Auris Nasus Larynx. 2018 Oct;45(5):1086-1092. doi: 10.1016/j.anl.2018.02.008. Epub 2018 Mar 19. Auris Nasus Larynx. 2018. PMID: 29567334 Clinical Trial.
Head and neck cancer fungating wounds: a novel odour transferrer.
Ota H, Ueki Y, Yamazaki K, Shodo R, Takahashi T, Yokoyama Y, Horii A. Ota H, et al. Among authors: yokoyama y. BMJ Support Palliat Care. 2024 Jan 8;13(e3):e833-e835. doi: 10.1136/spcare-2022-003824. BMJ Support Palliat Care. 2024. PMID: 36028291
Head and neck small-cell carcinoma: A multicenter study of 39 cases from 10 institutions.
Matsuyama H, Ueki Y, Okamoto I, Nagao T, Honda K, Yamazaki K, Okabe R, Togashi T, Shodo R, Ota H, Takahashi T, Omata J, Yokoyama Y, Saijo K, Tanaka R, Tsukahara K, Kitahara T, Uemura H, Yoshimoto S, Matsumoto F, Okami K, Sakai A, Takano K, Kondo A, Inohara H, Eguchi H, Oridate N, Tanabe T, Nakamizo M, Yokoshima K, Miura K, Kitani Y, Horii A. Matsuyama H, et al. Among authors: yokoyama y. Front Surg. 2022 Nov 14;9:1049116. doi: 10.3389/fsurg.2022.1049116. eCollection 2022. Front Surg. 2022. PMID: 36451679 Free PMC article.
Chemoradiotherapy with 3-weekly CDDP 80 mg/m2 for head and neck squamous cell carcinoma: 5-year survival data from a phase 2 study.
Otaki K, Takahashi T, Tanaka R, Saijo K, Omata J, Yokoyama Y, Shodo R, Ueki Y, Yamazaki K, Ota H, Togashi T, Takahashi N, Okabe R, Matsuyama H, Horii A. Otaki K, et al. Among authors: yokoyama y. Front Surg. 2022 Dec 16;9:1035349. doi: 10.3389/fsurg.2022.1035349. eCollection 2022. Front Surg. 2022. PMID: 36589621 Free PMC article.
Multicenter prospective phase II trial of concurrent chemoradiotherapy with weekly low-dose carboplatin for cisplatin-ineligible patients with advanced head and neck squamous cell carcinoma.
Ueki Y, Ohshima S, Yokoyama Y, Takahashi T, Shodo R, Yamazaki K, Ohtaki K, Saijo K, Tanaka R, Togashi T, Sato Y, Takano S, Omata J, Takahashi N, Okabe R, Horii A. Ueki Y, et al. Among authors: yokoyama y. Int J Clin Oncol. 2024 Jan;29(1):20-26. doi: 10.1007/s10147-023-02423-w. Epub 2023 Oct 16. Int J Clin Oncol. 2024. PMID: 37843751 Clinical Trial.
2,625 results